ClotCare: Blood Clots, Stroke, Heart Attack
Sunday, May 26, 2024
Home   |   DVT/PE   |   Blood Clots   |   Coumadin/Warfarin   |   New Patients   |   Self Testing   |   Email List   |   Donate

Pick a Topic:

Find info on a:

We subscribe to the HONcode principles of the HON Foundation. Click to verify.
ClotCare complies with the HONcode standard for trustworthy health
verify here.

ClotCare is a member of the Coalition to Prevent Deep Vein Thrombosis (DVT Coalition)  ClotCare is a member organization of the Coalition to Prevent Deep Vein Thrombosis. Click here to learn more about the Coalition to Prevent Deep Vein Thrombosis and DVT Awareness Month, which is held each March.

Acting Surgeon General Issues "Call to Action to Prevent Deep Vein Thrombosis and Pulmonary Embolism"

Click here to learn more about the Surgeon General's Call to Action from ClotCare Editorial Board Member Samuel Z. Goldhaber, MD on the ClotBlog.

Monday September 15, 2008
Contact: Office of Public Health and Science
(202) 205-0143

Acting Surgeon General Steven K. Galson, M.D., M.P.H., today issued a Call to Action to reduce the number of cases of deep vein thrombosis and pulmonary embolism in the United States.

Galson urged all Americans to learn about and prevent these treatable conditions.

Deep vein thrombosis and pulmonary embolism affect an estimated 350,000 to 600,000 Americans each year, and the numbers are expected to increase as the U.S. population ages. Together, deep vein thrombosis and pulmonary embolism contribute to at least 100,000 deaths each year.

Deep vein thrombosis is a blood clot in a deep vein, most commonly in the lower leg or thigh. The clot can block blood flow and cause pain, swelling, and skin discoloration.

In the most serious cases, deep vein thrombosis can lead to a pulmonary embolism - when part of the blood clot breaks loose and travels through the bloodstream to the lungs, where it can block a lung artery, causing damage to the lungs or other organs from lack of oxygen.

"Deep vein thrombosis and pulmonary embolisms are often 'silent' conditions - they can occur suddenly and without symptoms," Galson said. "But we have made a lot of progress in understanding how these disorders develop and how to prevent, diagnose, and treat them. It's time to put this knowledge into action."

Researchers have found that in most cases, deep vein thrombosis and pulmonary embolism develops in people who have an inherited blood clotting disorder or other risk factor, and who experience a triggering event.

"Being hospitalized or confined to bed rest, having major surgery, suffering a trauma, or traveling for several hours can increase a person's risk of deep vein thrombosis and pulmonary embolism," Galson said. "We want to increase the awareness and knowledge of these potentially deadly conditions and encourage patients and health care providers to take the steps to prevent them."

The Call to Action urges a coordinated, multifaceted plan to reduce the numbers of cases of deep vein thrombosis and pulmonary embolism nationwide. The plan emphasizes the need for:

  • Increased awareness about deep vein thrombosis and pulmonary embolism.
  • Evidence-based practices for deep vein thrombosis.
  • More research on the causes, prevention, and treatment of deep vein thrombosis.

The Call to Action resulted from a Surgeon General's Workshop on Deep Vein Thrombosis which was convened in May 2006. The workshop was co-sponsored by the National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health.

"Deep vein thrombosis and pulmonary embolism are major public health problems, and NHLBI is committed to continuing to support important basic and clinical research to advance our understanding of these disabling and potentially fatal conditions," NHLBI Director Elizabeth G. Nabel, M.D., noted. "Research is shedding light on genetic factors and the role of triggering events, behaviors, and conditions that increase the risk of developing dangerous blood clots. It is imperative that clinicians and public health experts work together to translate this scientific evidence to save lives."

The Agency for Healthcare Research and Quality (AHRQ) contributed to the Call to Action with the release of two new guides - one for patients and another for health care providers - on how to prevent dangerous blood clots. "Fighting deep vein thrombosis and pulmonary embolism is a team effort that involves health care providers and patients," said AHRQ Director Carolyn M. Clancy, M.D.

The Surgeon General's Call to Action to Prevent Deep Vein Thrombosis and Pulmonary Embolism 2008, is available at To order, contact the NHLBI Health Information Center at 301-592-8573 or at

Ask a question about blood clots or anticoagulant medications Have questions? Ask ClotCare. Send questions by email to

ClotCare is a 501(c)(3) non-profit organization generously supported by your tax-deductible donations and grants from our industry supporters.

Blood Clot Activities Calendar

New Postings:

Click here to view full list of new postings
ClotCare Home | New Postings | Patient Postings | Clinician Postings | Join Our Email List | Useful Web Links
CE Opportunities | Training Programs | DVT & PE Stories | Editorial Board | Financial Support
About ClotCare | DVT Coalition | Donate to ClotCare | Contact Us
Key topics discussed on ClotCare include: Blood Clots | Deep Vein Thrombosis (DVT) | Pulmonary Embolism (PE) | Atrial Fibrillation (A. Fib or AF) | Heart Attack | Stroke | Transient Ischemic Attack (TIA) | Mini Stroke | Bleeding Complications | Vascular Surgery | Surgical Blood Clot Removal | Warfarin | Coumadin | Lovenox | Low Molecular Weight Heparin (LMWH) | Heparin | Anticoagulants | Plavix | Aspirin | Antiplatelets | Blood Thinners
Copyright 2000-2018 by ClotCare. All rights reserved.
Terms, Conditions, & Privacy | Image Copyright Information
19260 Stone Oak Parkway, Suite 101 | San Antonio, TX 78258 | 210-860-0487
Send comments to
Sunday, May 26, 2024